{"id":5448,"date":"2025-03-12T10:23:47","date_gmt":"2025-03-12T13:23:47","guid":{"rendered":"https:\/\/gcimas.com\/?p=5448"},"modified":"2025-03-27T10:44:41","modified_gmt":"2025-03-27T13:44:41","slug":"decreto-80-025-reglamentacion-relativa-a-operador-farmaceutico-en-zona-franca","status":"publish","type":"post","link":"https:\/\/gcimas.com\/en\/novedades\/decreto-80-025-reglamentacion-relativa-a-operador-farmaceutico-en-zona-franca\/","title":{"rendered":"Decreto 80\/025 &#8211; Reglamentaci\u00f3n Relativa a &#8220;Operador Farmac\u00e9utico en Zona Franca&#8221;"},"content":{"rendered":"<h4>Extracto:<\/h4>\n<p>Decreto 80\/025 &#8211; Reglamentaci\u00f3n Relativa a &#8220;Operador Farmac\u00e9utico en Zona Franca&#8221;<\/p>\n<p>VISTO: la necesidad de estimular la actividad comercial desarrollada en zonas francas;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<\/p>\n<p>RESULTANDO: I) que diversas empresas act\u00faan en zonas francas, como operadores farmac\u00e9uticos, careciendo de una reglamentaci\u00f3n adecuada para el desarrollo de sus actividades;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-II) que el art\u00edculo 1 del Decreto &#8211; Ley N\u00b0 15.443, de 5 de agosto de 1983, comete al Poder Ejecutivo, regular la importaci\u00f3n, representaci\u00f3n, producci\u00f3n, elaboraci\u00f3n y comercializaci\u00f3n de los medicamentos y dem\u00e1s productos afines de uso humano, bajo el principio general de libertad de industria y comercio;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<\/p>\n<p>CONSIDERANDO: I) que resulta imprescindible adoptar aquellas medidas que potencien a nuestro pa\u00eds como hub regional en el sector de medicamentos de uso humano, productos afines y materias primas, lo que contribuir\u00e1 a la captaci\u00f3n de inversiones, generaci\u00f3n de empleo calificado, incremento y diversificaci\u00f3n de las exportaciones en productos de alto valor agregado;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;II) que corresponde por tanto reglamentar la operativa de determinadas empresas que desarrollan actividades reguladas por el Ministerio de Salud P\u00fablica dentro de las zonas francas;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<\/p>\n<p><a href=\"https:\/\/gcimas.com\/wp-content\/uploads\/2025\/03\/msp_509.pdf\" target=\"_blank\" rel=\"noopener\">Puede acceder al texto completo publicado aqu\u00ed<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Extracto: Decreto 80\/025 &#8211; Reglamentaci\u00f3n Relativa a &#8220;Operador Farmac\u00e9utico en Zona Franca&#8221; VISTO: la necesidad de estimular la actividad comercial desarrollada en zonas francas;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211; RESULTANDO: I) que diversas empresas act\u00faan en zonas francas, como operadores farmac\u00e9uticos, careciendo de una reglamentaci\u00f3n adecuada para el desarrollo de sus actividades;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;-II) que el art\u00edculo 1 del Decreto &#8211; Ley [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":5451,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[17],"tags":[],"class_list":["post-5448","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-novedades"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/gcimas.com\/en\/wp-json\/wp\/v2\/posts\/5448","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gcimas.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gcimas.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gcimas.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/gcimas.com\/en\/wp-json\/wp\/v2\/comments?post=5448"}],"version-history":[{"count":0,"href":"https:\/\/gcimas.com\/en\/wp-json\/wp\/v2\/posts\/5448\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/gcimas.com\/en\/wp-json\/wp\/v2\/media\/5451"}],"wp:attachment":[{"href":"https:\/\/gcimas.com\/en\/wp-json\/wp\/v2\/media?parent=5448"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gcimas.com\/en\/wp-json\/wp\/v2\/categories?post=5448"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gcimas.com\/en\/wp-json\/wp\/v2\/tags?post=5448"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}